Article
Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer?
Surgery - 1 Dec 2012
Lee Kathleen C, Li Carol, Schneider Eric B, Wang Yongchun, Somervell Helina, Krafft Matthew, Umbricht Christopher B, Zeiger Martha A
Abstract excerpt
BACKGROUND: Some have proposed using V600E BRAF mutation status to dictate the surgical management of patients with papillary thyroid cancer (PTC). However, well-designed studies examining BRAF association with aggressive clinicopathologic features of PTC, including the presence of lymph node metastases (LNM), in patients who have undergone routine central lymph node dissection (CLND), are lacking. METHODS: Under...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
